Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 45 citing articles:

Antioxidant and anti-inflammatory agents in chronic liver diseases: Molecular mechanisms and therapy
Chunye Zhang, Shuai Liu, Ming Yang
World Journal of Hepatology (2023) Vol. 15, Iss. 2, pp. 180-200
Open Access | Times Cited: 44
A comprehensive evaluation of the therapeutic potential of silibinin: a ray of hope in cancer treatment
Pantha Prodip Ray, Mohammad Ashraful Islam, Mohammad Safiqul Islam, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 16
Rutin and Quercetin Counter Doxorubicin-Induced Liver Toxicity in Wistar Rats via Their Modulatory Effects on Inflammation, Oxidative Stress, Apoptosis, and Nrf2
Osama M. Ahmed, Mohammed H. Elkomy, Hanaa I. Fahim, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-19
Open Access | Times Cited: 52
Combining Crocin and Sorafenib Improves Their Tumor-Inhibiting Effects in a Rat Model of Diethylnitrosamine-Induced Cirrhotic-Hepatocellular Carcinoma
Basma Awad, Alaaeldin Ahmed Hamza, Amna Al-Maktoum, et al.
Cancers (2023) Vol. 15, Iss. 16, pp. 4063-4063
Open Access | Times Cited: 37
Silymarin in cancer therapy: Mechanisms of action, protective roles in chemotherapy-induced toxicity, and nanoformulations
Yin Wang, Ai-Jun Yuan, Yuejin Wu, et al.
Journal of Functional Foods (2022) Vol. 100, pp. 105384-105384
Open Access | Times Cited: 30
Advances in mitophagy and mitochondrial apoptosis pathway-related drugs in glioblastoma treatment
Weiping Li, Xia Xu
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 16
A review of the botany, phytochemistry, pharmacology, synthetic biology and comprehensive utilization of Silybum marianum
Xiaozhuang Zhang, Meiqi Liu, Zhen Wang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 6
Correlation of the anticancer and pro-oxidant behavior and the structure of flavonoid-oxidovanadium(IV) complexes
Luciana G. Naso, Evelina G. Ferrer, Patricia A.M. Williams
Coordination Chemistry Reviews (2023) Vol. 492, pp. 215271-215271
Closed Access | Times Cited: 12
A large-scale transcriptional analysis reveals herb-derived ginsenoside F2 suppressing hepatocellular carcinoma via inhibiting STAT3
Xue Tan, Xiaofang Ma, Yifei Dai, et al.
Phytomedicine (2023) Vol. 120, pp. 155031-155031
Closed Access | Times Cited: 12
Recent advances of novel targeted drug delivery systems based on natural medicine monomers against hepatocellular carcinoma
Guanjie Ji, Yue Li, Zhiyue Zhang, et al.
Heliyon (2024) Vol. 10, Iss. 2, pp. e24667-e24667
Open Access | Times Cited: 4
Silybin: A Review of Its Targeted and Novel Agents for Treating Liver Diseases Based on Pathogenesis
Jijiao Wu, Wen Lin, Xiaolian Liu, et al.
Phytotherapy Research (2024)
Closed Access | Times Cited: 4
Flavonoids in natural products for the therapy of liver diseases: progress and future opportunities
Yanmei Liao, Fei Lv, Tianwen Quan, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
Silymarin: a promising modulator of apoptosis and survival signaling in cancer
Ujjawal Sharma, Praveen Kumar Sahni, Bunty Sharma, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Isatin Counteracts Diethylnitrosamine/2-Acetylaminofluorene-Induced Hepatocarcinogenesis in Male Wistar Rats by Upregulating Anti-Inflammatory, Antioxidant, and Detoxification Pathways
Nagwa G. Tawfik, Wafaa R. Mohamed, Hanan S. Mahmoud, et al.
Antioxidants (2022) Vol. 11, Iss. 4, pp. 699-699
Open Access | Times Cited: 17
Action of Carduus marianus 6cH on Hepatopathy and Gallstone in Ambystoma mexicanum (Axolotl): Case Report
Jéssica Amâncio Martins, Melina Castilho de Souza Balbueno, Cidéli de Paula Coelho
Homeopathy (2024)
Closed Access | Times Cited: 3
Silibinin, a commonly used therapeutic agent for non‐alcohol fatty liver disease, functions through upregulating intestinal expression of fibroblast growth factor 15/19
Yujie Bai, Jing Zhang, Jialin Li, et al.
British Journal of Pharmacology (2024) Vol. 181, Iss. 19, pp. 3663-3684
Closed Access | Times Cited: 3
Rosuvastatin attenuates total-tau serum levels and increases expression of miR-124-3p in dyslipidemic Alzheimer's patients: a historic cohort study
Farnoosh Usefi, Auob Rustamzadeh, Zahra Ghobadi, et al.
Metabolic Brain Disease (2024) Vol. 39, Iss. 6, pp. 1201-1211
Closed Access | Times Cited: 3
Targeting Wnt-β-Catenin Signaling Pathway for Hepatocellular Carcinoma Nanomedicine
Anita K. Bakrania, Jeffrey C. To, Gang Zheng, et al.
Gastro Hep Advances (2023) Vol. 2, Iss. 7, pp. 948-963
Open Access | Times Cited: 8
Novel Strategies Enhancing Bioavailability and Therapeutical Potential of Silibinin for Treatment of Liver Disorders
Michal Šelc, Radka Macova, Andrea Bábelová
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 4629-4659
Open Access | Times Cited: 2
The anticarcinogenic effect of eugenol on lung cancer induced by diethylnitrosamine/2-acetylaminofluorene in Wistar rats: insight on the mechanisms of action
Hadeer M. Morsy, Osama M. Ahmed, Khairy M. A. Zoheir, et al.
APOPTOSIS (2023) Vol. 28, Iss. 7-8, pp. 1184-1197
Open Access | Times Cited: 6
Chronic Administration of Diethylnitrosamine and 2-Acetylaminofluorene Induces Hepatocellular Carcinoma in Wistar Rats
Jaime Sánchez-Meza, Marina Campos-Valdez, José Alfredo Domínguez‐Rosales, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8387-8387
Open Access | Times Cited: 6
Combinatorial treatment with Silybum marianum essential oil enhances the therapeutic efficacy of a 5‐fluorouracil base therapy for hepatocellular carcinoma
Mohammad Jaber MasodKhooy, Massoumeh Farasat, Mohamadreza Salehi Salmi, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 5, pp. 1968-1985
Closed Access | Times Cited: 5
Construction of a Necroptosis-Related miRNA Signature for Predicting the Prognosis of Patients With Hepatocellular Carcinoma
Tongyu Meng, Qingfeng Wang, Yufeng Yang, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 8
Protective Effects of Naringin–Dextrin Nanoformula against Chemically Induced Hepatocellular Carcinoma in Wistar Rats: Roles of Oxidative Stress, Inflammation, Cell Apoptosis, and Proliferation
Eman E. Mohamed, Osama M. Ahmed, Adel Abdel‐Moneim, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 12, pp. 1558-1558
Open Access | Times Cited: 8
Milk thistle nano-micelle formulation promotes cell cycle arrest and apoptosis in hepatocellular carcinoma cells through modulating miR-155-3p /SOCS2 /PHLDA1 signaling axis
Saghar Rahnama, Zahra Moazezi Tehrankhah, Fatemeh Mohajerani, et al.
BMC Complementary Medicine and Therapies (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top